FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
ARTUS C. DIFFICILE QS-RGQ MDX KIT
K Number: K133936
·
Decision Apr 4, 2014
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
16
Applicant Total
13
Review Days
102
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- ARTUS C. DIFFICILE QS-RGQ MDX KIT
- K Number
- K133936
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3130
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- QIAGEN GmbH
- Date Received
- December 23, 2013
- Decision Date
- April 4, 2014
- Product Code
- OZN
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OZN | C. Difficile Toxin Gene Amplification Assay | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (OZN), ordered by most recent decision date.
Xpert C. difficile/Epi
FDA 510(k)
FDA Class 2
·Microbiology
Great Basin Toxigenic C. difficile Direct Test (CDF2)
FDA 510(k)
FDA Class 2
·Microbiology
cobas Cdiff nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
cobas Cdiff nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
GenePOC CDiff
FDA 510(k)
FDA Class 2
·Microbiology
cobas Cdiff Nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by QIAGEN GmbH
| K Number | Device Name | ||
|---|---|---|---|
| K254032 | QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B | Mar 9, 2026 | Substantially Equivalent |
| K252329 | QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B | Oct 22, 2025 | Substantially Equivalent |
| K250080 | QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini | Aug 27, 2025 | Substantially Equivalent |
| K250324 | QIAstat-Dx GI Panel 2 Mini B | Feb 28, 2025 | Substantially Equivalent |
| K243813 | QIAstat-Dx GI Panel 2 Mini B&V | Jan 8, 2025 | Substantially Equivalent |
| K242256 | QIAstat-Dx Meningitis/Encephalitis (ME) Panel | Oct 29, 2024 | Substantially Equivalent |
| K242353 | QIAstat-Dx Respiratory Panel Mini | Oct 25, 2024 | Substantially Equivalent |
| K220062 | QIAstat-Dx Gastrointestinal Panel 2 | May 31, 2024 | Substantially Equivalent |
| K233100 | QIAstat-Dx® Respiratory Panel Plus | May 10, 2024 | Substantially Equivalent |
| K183597 | QIAstat-Dx Respiratory Panel | May 18, 2019 | Substantially Equivalent |